Life Sciences

Point-of-care AI: The New Imperative for Pharma Commercial Strategy

Thu, April 25, 2024 1:00 PM - EST

With complex care pathways, diagnosis delays and fragmented care delivery, pharma brands face multiple challenges getting treatments to patients. In this panel discussion, industry experts will share how point-of-care AI is effectively being used to overcome these challenges by streamlining care workflows, accelerating time to diagnosis and therapy, and ultimately, improving patient outcomes.

Join the webinar to learn why point-of-care AI is the new imperative for pharma commercial strategy:

  • Realize the promise of AI to drive brand success and improve delivery of care to diverse patient populations
  • Identify how AI is contributing to advancements in personalized medicine and targeted therapies
  • Address healthcare disparities and improve patient outcomes through illustrated initiatives leveraging AI
  • Hear how AI technologies are being used to help optimize HCP workflows and patient journeys

Youssef Idelcaid

Head of Data Science - Commercial, Medical Affairs & Government Affairs, Genentech

Anurag Gupta

Senior Director of Data Science & AI, US Oncology Business, AstraZeneca

Sommer Bazuro

Chief Medical Officer, IPG Health

Nina Binetti

VP Marketing,